# COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure

> **NCT05734690** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 503 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** SGLT2i, beta blocker, ARNI, MRA, MTD
- **BEHAVIORAL:** Education-First

## Key facts

- **NCT ID:** NCT05734690
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-05
- **Primary completion:** 2025-05-19
- **Final completion:** 2025-06-09
- **Target enrollment:** 503 (ACTUAL)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734690, "COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05734690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*